Last $7.92 USD
Change Today 0.00 / 0.00%
Volume 0.0
523620 On Other Exchanges
Symbol
Exchange
523620 is not on other exchanges.
As of 8:04 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

pharmasia ltd (523620) Snapshot

Open
$7.88
Previous Close
$7.92
Day High
$7.92
Day Low
$7.88
52 Week High
02/20/14 - $19.00
52 Week Low
01/13/15 - $7.61
Market Cap
12.7M
Average Volume 10 Days
2.8K
EPS TTM
$0.26
Shares Outstanding
1.6M
EX-Date
--
P/E TM
30.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMASIA LTD (523620)

Related News

No related news articles were found.

pharmasia ltd (523620) Related Businessweek News

No Related Businessweek News Found

pharmasia ltd (523620) Details

Phaarmasia Limited manufactures and sells pharmaceutical products and bulk drugs primarily in India. The company offers formulations, cosmetics and oral contraceptive pills. It also provides skin/face creams and tooth paste. The company was incorporated in 1981 and is based in Hyderabad, India.

Founded in 1981

pharmasia ltd (523620) Top Compensated Officers

Managing Director and Executive Director
Total Annual Compensation: --
Whole-Time Director, Member of Audit Committe...
Total Annual Compensation: 540.0K
Compensation as of Fiscal Year 2013.

pharmasia ltd (523620) Key Developments

Phaarmasia Limited Announces Standalone Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Phaarmasia Limited announced standalone unaudited earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported total income from operations of INR 28.171 million against INR 48.720 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 0.969 million against INR 1.057 million a year ago. Profit before tax was INR 0.902 million against INR 1.048 million a year ago. Net profit was INR 0.631 million against INR 0.724 million a year ago. Earnings per basic and diluted share were INR 0.0925 against INR 0.11 a year ago. For the six months, the company reported total income from operations of INR 57.560 million against INR 97.484 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1.942 million against INR 2.060 million a year ago. Profit before tax was INR 1.856 million against INR 2.017 million a year ago. Net profit was INR 1.299 million against INR 1.394 million a year ago. Earnings per basic and diluted share were INR 0.1903 against INR 0.2042 a year ago.

Phaarmasia Limited, Board Meeting, Nov 14, 2014

Phaarmasia Limited, Board Meeting, Nov 14, 2014. Agenda: To consider quarterly results.

Phaarmasia Limited, Annual General Meeting, Sep 24, 2014

Phaarmasia Limited, Annual General Meeting, Sep 24, 2014., at 15:00 Indian Standard Time. Agenda: To consider re-appointment of Mr. Maneesh R. Sapte as Managing Director; to consider re-appointment of Mr. Bharat Merchant Bachubhai as Director; and to consider re-appointment of Mr. Mr. Bhupinder Narendra Garg as Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHRM:IN 12.78 INR +0.60

523620 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 523620.
View Industry Companies
 

Industry Analysis

523620

Industry Average

Valuation 523620 Industry Range
Price/Earnings 25.4x
Price/Sales 0.8x
Price/Book 1.2x
Price/Cash Flow 17.4x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMASIA LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.